Molina Healthcare (NYSE:MOH) Issues Q2 2025 Earnings Guidance

Molina Healthcare (NYSE:MOH - Get Free Report) issued an update on its second quarter 2025 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of 5.500-5.500 for the period, compared to the consensus estimate of 6.210. The company issued revenue guidance of -. Molina Healthcare also updated its FY 2025 guidance to 21.500-22.500 EPS.

Molina Healthcare Stock Down 0.6%

Shares of MOH stock traded down $1.33 during mid-day trading on Tuesday, hitting $231.28. The stock had a trading volume of 395,574 shares, compared to its average volume of 705,984. Molina Healthcare has a 12-month low of $229.85 and a 12-month high of $365.23. The firm has a market capitalization of $12.54 billion, a P/E ratio of 11.17, a price-to-earnings-growth ratio of 0.80 and a beta of 0.55. The firm's 50-day moving average is $300.51 and its two-hundred day moving average is $305.19. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.63 and a quick ratio of 1.63.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share for the quarter, topping the consensus estimate of $5.96 by $0.12. The business had revenue of $11.15 billion during the quarter, compared to analysts' expectations of $10.86 billion. Molina Healthcare had a return on equity of 28.38% and a net margin of 2.81%. The business's revenue for the quarter was up 12.2% compared to the same quarter last year. During the same period in the prior year, the business earned $5.73 EPS. On average, analysts predict that Molina Healthcare will post 24.4 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on MOH. Wall Street Zen cut Molina Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, June 29th. Robert W. Baird restated a "neutral" rating and set a $375.00 price objective (up from $331.00) on shares of Molina Healthcare in a research note on Tuesday, April 15th. Sanford C. Bernstein initiated coverage on Molina Healthcare in a research note on Tuesday, April 22nd. They set an "outperform" rating and a $414.00 price objective for the company. Guggenheim initiated coverage on Molina Healthcare in a research note on Wednesday, April 9th. They issued a "neutral" rating for the company. Finally, Baird R W cut Molina Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Ten investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $364.21.

Insider Transactions at Molina Healthcare

In other news, Director Richard M. Schapiro sold 669 shares of the stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $320.50, for a total value of $214,414.50. Following the transaction, the director directly owned 11,244 shares of the company's stock, valued at approximately $3,603,702. This represents a 5.62% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total value of $28,005,250.00. Following the completion of the transaction, the chief executive officer directly owned 257,715 shares in the company, valued at $82,484,262.90. This represents a 25.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.10% of the stock is currently owned by corporate insiders.

Institutional Trading of Molina Healthcare

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Focus Partners Wealth grew its holdings in Molina Healthcare by 82.7% during the first quarter. Focus Partners Wealth now owns 3,749 shares of the company's stock worth $1,235,000 after acquiring an additional 1,697 shares during the period. Woodline Partners LP acquired a new stake in Molina Healthcare during the first quarter worth about $1,541,000. Goldman Sachs Group Inc. grew its holdings in Molina Healthcare by 19.4% during the first quarter. Goldman Sachs Group Inc. now owns 249,466 shares of the company's stock worth $82,172,000 after acquiring an additional 40,531 shares during the period. Jones Financial Companies Lllp grew its holdings in Molina Healthcare by 713.3% during the first quarter. Jones Financial Companies Lllp now owns 1,651 shares of the company's stock worth $544,000 after acquiring an additional 1,448 shares during the period. Finally, NewEdge Advisors LLC boosted its position in Molina Healthcare by 33.4% during the first quarter. NewEdge Advisors LLC now owns 1,106 shares of the company's stock worth $364,000 after purchasing an additional 277 shares in the last quarter. 98.50% of the stock is owned by institutional investors and hedge funds.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.